The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis
Abstract
Bakker A, van Balkom AJLM, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis. Acta Psychiatr Scand 2002: 106: 163–167. © Blackwell Munksgaard 2002. Objective: To compare the short‐term efficacy of selective serotonin reuptake inhibitors (SSRIs) vs. tricyclic antidepressants (TCAs) in the treatment of panic disorder (PD) a meta‐analysis was conducted. Method: Included were 43 studies (34 randomized, nine open), pertaining to 53 treatment conditions, 2367 patients at pretest and 1804 at post‐test. Outcome was measured with the proportion of patients becoming panic‐free, and with pre/post Cohen's d effect sizes, calculated for four clinical variables: panic, agoraphobia, depression, and general anxiety. Results: There were no differences between SSRIs and TCAs on any of the effect sizes, indicating that both groups of antidepressants are equally effective in reducing panic symptoms, agoraphobic avoidance, depressive symptomatology and general anxiety. Also the percentage of patients free of panic attacks at post‐test did not differ. The number of drop‐outs, however, was significantly lower in the group of patients treated with SSRIs (18%) vs. TCAs (31%). Conclusion: SSRIs and TCAs are equal in efficacy in the treatment of panic disorder, but SSRIs are tolerated better.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
VAN BALKOM, A. J. L. M., BAKKER, A., SPINHOVEN, P., BLAAUW, B. M. J. W., SMEENK, S., & RUESINK, B. (1997) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199708000-00006 · Cited by 211 · cited 7×
“psychotherapy before, that showed no significant differences in efficacy between these types of interventions (3).”
BackgroundMethodResultInfluentialSelf-citationSchweizer, E. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130053009 · Cited by 120
Research works printed but not linked: 45
- 10.1017/S0033291700029986 · DOI
- 10.1097/00004850-199503000-00006 · DOI · Paper page
- 10.1002/(SICI)1522-7154(1996)2:4<192::AID-ANXI6>3.0.CO;2-Q · DOI
- 10.1111/j.1600-0447.1997.tb00388.x · DOI
- 10.1192/bjp.170.6.549 · DOI
- 10.4088/JCP.v60n1205 · DOI
- PAPP LA, Clomipramine treatment of panic disorder: pros and cons, J Clin Psychiatry, 58, 423, 10.4088/JCP.v58n1002 · DOI
- 10.1176/appi.ajp.158.12.1989 · DOI · Paper page
- 10.1111/j.1600-0447.1991.tb03097.x · DOI
- 10.1016/0165-0327(88)90054-7 · DOI
- CHARNEY DS, 1986, Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam and trazodone, J Clin Psychiatry, 47, 580
- 10.1176/ajp.141.3.446 · DOI
- 10.1002/hup.470050209 · DOI
- 10.1192/bjp.143.4.348 · DOI
- 10.1001/archpsyc.1989.01810020029006 · DOI
- 10.1016/0010-440X(85)90052-5 · DOI
- 10.1159/000284627 · DOI
- SVEBAK S, 1990, Clonazepam and imipramine in the treatment of panic attacks: a double‐blind comparison of efficacy and side effects, J Clin Psychiatry, 51, 14
- 10.1097/00004714-199004000-00006 · DOI
- 10.1016/0005-7967(85)90011-7 · DOI · Paper page
- 10.1016/S0006-3223(97)00376-4 · DOI
- SHEAR MK, 1995, Pattern of placebo response in panic disorder, Psychopharmacol Bull, 31, 273
- 10.1176/ajp.152.5.673 · DOI
- 10.1097/00004714-199208000-00007 · DOI
- 10.1176/ajp.138.9.1215 · DOI
- 10.1001/archpsyc.1988.01800290073009 · DOI
- 10.1176/ajp.155.5.603 · DOI · Paper page
- 10.1016/0165-0327(91)90003-B · DOI
- 10.1097/00004714-198806000-00010 · DOI
- 10.1001/archpsyc.1993.01820130046008 · DOI · Paper page
- 10.1007/BF02245749 · DOI · Paper page
- 10.1097/00004850-198801000-00005 · DOI · Paper page
- 10.1097/00004714-199608000-00005 · DOI
- 10.4088/JCP.v57n1107 · DOI
- 10.1016/0887-6185(96)00008-4 · DOI
- SPIEGEL DA, 1996, An open trial of fluvoxamine therapy for panic disorder complicated by depression, J Clin Psychiatry, 57, 37
- 10.1097/00004714-198710000-00007 · DOI · Paper page
- 10.1097/00004714-199004000-00007 · DOI
- 10.1176/ajp.155.11.1570 · DOI
- 10.1097/00004850-199710006-00006 · DOI
- PECKNOLD JC, 1995, Fluoxetine in panic disorder. pharmacologic and tritiated platelet imipramine and paroxetine binding study, J Psychiatry Neuroscience, 20, 193
- 10.1176/ajp.155.1.36 · DOI · Paper page
- 10.1097/00004850-199206005-00003 · DOI
- 10.1001/archpsyc.55.11.1010 · DOI
- 10.1176/ajp.155.9.1189 · DOI
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
Mitte, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.003 · Cited by 396
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Depression and Anxiety in People with Epilepsy
Kwon, O.-Y., & Park, S.-P. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.3.175 · Cited by 294
Metadata
- Authors
- Bakker, A., Van Balkom, A. J. L. M., & Spinhoven, P.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2002-08-28
- Volume
- 106
- Issue
- 3
- Pages
- 163-167
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1989558433
- Cited by
- 184
- References
- 4
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis. https://app.cochat.ai/papers/10.1034/j.1600-0447.2002.02255.x
- The paper
- Bakker, A., Van Balkom, A. J. L. M., & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: a meta‐analysis. Acta Psychiatrica Scandinavica. https://doi.org/10.1034/j.1600-0447.2002.02255.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.